SALEKI AZITA — SEC insider filings

SEC reporting owner CIK 1563545. 26 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2020-11-06 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AbbVie Inc. (ABBV)EVP, CHIEF OPERATIONS OFFICER20—12 legs · 271,176 sh · $39,757,89955
ENTEGRIS INC (ENTG)Director6——6

Insider filings — SALEKI AZITA

FiledFormIssuerReported transactionsSource
2026-11-184AbbVie Inc. (ABBV)Option exercise (M): 23,935 @ $61.36 · Tax withholding (F): 13,481 @ $298.55 · Option exercise (M): 13,481 (derivative) @ $0EDGAR
2026-05-084ENTEGRIS INC (ENTG)Grant/award (A): 1,412 @ $0EDGAR
2026-03-034AbbVie Inc. (ABBV)Tax withholding (F): 16,309 @ $232.08EDGAR
2026-02-204AbbVie Inc. (ABBV)Grant/award (A): 17,041 @ $0 · Grant/award (A): 6,058 @ $0 · Grant/award (A): 7,074 @ $0 · Grant/award (A): 6,638 @ $0 · Grant/award (A): 20,312 (derivative) @ $0EDGAR
2025-08-144AbbVie Inc. (ABBV)Option exercise (M): 42,370 @ $54.86 · Sale (S): 42,370 @ $198.42 · Option exercise (M): 42,370 (derivative) @ $54.86EDGAR
2025-04-254ENTEGRIS INC (ENTG)Grant/award (A): 2,897 @ $0EDGAR
2025-03-044AbbVie Inc. (ABBV)Tax withholding (F): 17,056 @ $205.02EDGAR
2025-02-184AbbVie Inc. (ABBV)Grant/award (A): 17,986 @ $0 · Grant/award (A): 7,378 @ $0 · Grant/award (A): 6,060 @ $0 · Grant/award (A): 7,074 @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-09-304AbbVie Inc. (ABBV)Gift (G): 25,630 @ $0EDGAR
2024-04-254ENTEGRIS INC (ENTG)Grant/award (A): 1,643 @ $0EDGAR
2024-03-014AbbVie Inc. (ABBV)Tax withholding (F): 23,966 @ $178.99EDGAR
2024-02-234AbbVie Inc. (ABBV)Option exercise (M): 52,870 @ $58.88 · Sale (S): 52,870 @ $173.71 · Option exercise (M): 52,870 (derivative) @ $58.88EDGAR
2024-02-204AbbVie Inc. (ABBV)Grant/award (A): 32,097 @ $0 · Grant/award (A): 8,558 @ $0 · Grant/award (A): 7,380 @ $0 · Grant/award (A): 6,060 @ $0 · Grant/award (A): 29,313 (derivative) @ $0EDGAR
2023-04-284ENTEGRIS INC (ENTG)Grant/award (A): 2,849 @ $0EDGAR
2023-03-024AbbVie Inc. (ABBV)Tax withholding (F): 33,359 @ $154.28 · Option exercise (M): 26,990 @ $51.42 · Sale (S): 26,990 @ $155 · Sale (S): 9,220 @ $153.05 · Sale (S): 780 @ $153.39 · Option exercise (M): 26,990 (derivative) @ $51.42EDGAR
2023-02-214AbbVie Inc. (ABBV)Grant/award (A): 48,127 @ $0 · Grant/award (A): 11,229 @ $0 · Grant/award (A): 8,560 @ $0 · Grant/award (A): 7,380 @ $0 · Option exercise (M): 25,000 @ $51.42 · Sale (S): 14,246 @ $149.13 · +3 moreEDGAR
2022-04-294ENTEGRIS INC (ENTG)Grant/award (A): 1,849 @ $0EDGAR
2022-03-014AbbVie Inc. (ABBV)Tax withholding (F): 22,108 @ $149.54EDGAR
2022-02-224AbbVie Inc. (ABBV)Grant/award (A): 25,612 @ $0 · Grant/award (A): 5,568 @ $0 · Grant/award (A): 11,229 @ $0 · Grant/award (A): 7,490 @ $0 · Grant/award (A): 13,837 @ $0 · Grant/award (A): 35,026 (derivative) @ $0EDGAR
2021-05-264AbbVie Inc. (ABBV)Option exercise (M): 12,400 @ $29.23 · Option exercise (M): 74,520 @ $35.88 · Sale (S): 77,863 @ $116.24 · Sale (S): 9,057 @ $116.70 · Option exercise (M): 12,400 (derivative) @ $0 · Option exercise (M): 74,520 (derivative) @ $0EDGAR
2021-05-034ENTEGRIS INC (ENTG)Grant/award (A): 1,610 @ $0EDGAR
2021-03-024AbbVie Inc. (ABBV)Tax withholding (F): 15,785 @ $107.74EDGAR
2021-02-224AbbVie Inc. (ABBV)Grant/award (A): 14,552 @ $0 · Grant/award (A): 4,279 @ $0 · Grant/award (A): 5,568 @ $0 · Grant/award (A): 11,229 @ $0 · Grant/award (A): 42,236 (derivative) @ $0EDGAR
2020-11-124AbbVie Inc. (ABBV)Sale (S): 17,426 @ $98EDGAR
2020-11-124/AAbbVie Inc. (ABBV)Option exercise (M): 4,800 @ $24.21 · Sale (S): 4,800 @ $93.61 · Option exercise (M): 4,800 (derivative) @ $0EDGAR
2020-11-064AbbVie Inc. (ABBV)Sale (S): 4,800 @ $93.61EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1563545 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs